- Home
- AFBI vs CTNM Comparison
AFBI vs CTNM Comparison
Compare AFBI & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- CTNM
- Stock Information
- Founded
- AFBI 1928
- CTNM 2009
- Country
- AFBI United States
- CTNM United States
- Employees
- AFBI N/A
- CTNM N/A
- Industry
- AFBI Major Banks
- CTNM
- Sector
- AFBI Finance
- CTNM
- Exchange
- AFBI Nasdaq
- CTNM Nasdaq
- Market Cap
- AFBI 117.0M
- CTNM 114.1M
- IPO Year
- AFBI N/A
- CTNM 2024
- Fundamental
- Price
- AFBI $18.10
- CTNM $3.66
- Analyst Decision
- AFBI
- CTNM Strong Buy
- Analyst Count
- AFBI 0
- CTNM 4
- Target Price
- AFBI N/A
- CTNM $22.50
- AVG Volume (30 Days)
- AFBI 8.4K
- CTNM 102.0K
- Earning Date
- AFBI 05-09-2025
- CTNM 05-14-2025
- Dividend Yield
- AFBI 8.29%
- CTNM N/A
- EPS Growth
- AFBI N/A
- CTNM N/A
- EPS
- AFBI 0.91
- CTNM N/A
- Revenue
- AFBI $31,043,000.00
- CTNM N/A
- Revenue This Year
- AFBI N/A
- CTNM N/A
- Revenue Next Year
- AFBI N/A
- CTNM N/A
- P/E Ratio
- AFBI $19.90
- CTNM N/A
- Revenue Growth
- AFBI 4.89
- CTNM N/A
- 52 Week Low
- AFBI $16.87
- CTNM $3.35
- 52 Week High
- AFBI $22.50
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- AFBI 44.03
- CTNM N/A
- Support Level
- AFBI $17.86
- CTNM N/A
- Resistance Level
- AFBI $19.00
- CTNM N/A
- Average True Range (ATR)
- AFBI 0.20
- CTNM 0.00
- MACD
- AFBI -0.07
- CTNM 0.00
- Stochastic Oscillator
- AFBI 21.05
- CTNM 0.00
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.